SCHEMBL29928376

SCHEMBL29928376

Clc1cnc2[nH]cc(Br)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.54
AXL P30530 1/20 0.47
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CDK2 P24941 2/20 0.39
FLT1 P17948 2/20 0.39
KDR P35968 2/20 0.39
FLT3 P36888 2/20 0.39
NTRK3 Q16288 2/20 0.39
AURKB Q96GD4 2/20 0.39
PLK4 O00444 1/20 0.39
AURKA O14965 1/20 0.39
ROCK2 O75116 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PRKCG P05129 1/20 0.39
INSR P06213 1/20 0.39
CDK1 P06493 1/20 0.39
FES P07332 1/20 0.39
IGF1R P08069 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666074 1.00 JAK2 (0.54) JAK2AXLCYP3A4CYP2C19CDK2
SCHEMBL15155041 0.77 GSK3B (0.56) JAK2CYP3A4CYP2C19CDK2FLT1
SCHEMBL14883424 0.77 JAK2 (0.54) JAK2AXLCYP3A4CYP2C19ITK
SCHEMBL1053943 0.77 JAK2 (0.58) JAK2AXLCYP3A4CYP2C19FLT1
SCHEMBL12657249 0.77 JAK2 (0.54) JAK2CYP3A4CYP2C19FLT1KDR
SCHEMBL14678434 0.77 AXL (0.47) JAK2AXLCYP3A4CDK2FLT1
SCHEMBL29605509 0.77 AXL (0.47) JAK2AXLCYP3A4CDK2FLT1
SCHEMBL91446 0.77 AXL (0.47) JAK2AXLCYP3A4CYP2C19CDK2
Ammonia Solution, Strong SCHEMBL27890807 0.76 JAK2 (0.57) JAK2AXLCYP3A4CYP2C19FLT1
SCHEMBL16463128 0.75 PARP1 (0.36) JAK2IGF1RCLK2CSNK2A1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447954-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS Icahn School of Medicine at Mount Sinai (US) 2024-10-23 EP disclosed
CN-118772152-A Azacyclic compounds as AAK1 inhibitors 艾立康药业股份有限公司 2024-10-15 CN disclosed
CN-118488947-A Condensed ring substituted six-membered heterocyclic compound, preparation method and application thereof 劲方医药科技(上海)有限公司 2024-08-13 CN disclosed
CN-112638477-B Pyrrolo [2,3-B ] pyridine derivatives as inhibitors of influenza virus replication 共晶制药公司 2024-01-26 CN disclosed
CN-117417355-A Fused heterocyclic compound, preparation method and application thereof 上海翊石医药科技有限公司 2024-01-19 CN disclosed
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN disclosed
WO-2023114472-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-06-22 WO disclosed
CN-110637022-B Pyrrolopyrimidine derivatives as inhibitors of influenza virus replication 共晶制药公司 2022-09-16 CN disclosed